Zhenyan Yan - GenScript | LinkedIn (2024)

Activity

• Proud to organize the 2024 SAPA Investment Forum @ JPM week with our volunteers. Many thanks to the panelists (Xiao-Dong Chen, Vicky W. Zhang, Lin…

  

  Proud to organize the 2024 SAPA Investment Forum @ JPM week with our volunteers. Many thanks to the panelists (Xiao-Dong Chen, Vicky W. Zhang, Lin…

  Liked by Zhenyan Yan

• Liked by Zhenyan Yan

  

  Liked by Zhenyan Yan

• The sun shining in A2 on the longest day of the year. ☀️

  

  The sun shining in A2 on the longest day of the year. ☀️

  Liked by Zhenyan Yan

Join now to see all activity

• In last week’s NCI Acquired Resistance to Therapy Network (ARTNet) meeting, I shared the 10-year timeline of my lab research project on the…

  

  In last week’s NCI Acquired Resistance to Therapy Network (ARTNet) meeting, I shared the 10-year timeline of my lab research project on the…

  Liked by Zhenyan Yan

• After an amazing 19 years at Novartis, I am excited to share that I'll be leaving to embark on new adventures to advance the Biotech ecosystem…

  

  After an amazing 19 years at Novartis, I am excited to share that I'll be leaving to embark on new adventures to advance the Biotech ecosystem…

  Liked by Zhenyan Yan

• Dear Colleagues and Friends,I am thrilled and humbled to share that I am running for election to the AUTM’s Board of Directors, and I am asking for…

  

  Dear Colleagues and Friends,I am thrilled and humbled to share that I am running for election to the AUTM’s Board of Directors, and I am asking for…

  Liked by Zhenyan Yan

• Dana-Farber scientists have now teased apart the relationship between the proteins EP300 and CBP to discover that EP300 is critical for a high-risk…

  

  Dana-Farber scientists have now teased apart the relationship between the proteins EP300 and CBP to discover that EP300 is critical for a high-risk…

  Liked by Zhenyan Yan

• Liked by Zhenyan Yan

  

  Liked by Zhenyan Yan

• At GSK Malaysia Sdn Bhd, we are incredibly proud to have 68% of our colleagues that are women. The diversity of our colleagues allows us to gain new…

  

  At GSK Malaysia Sdn Bhd, we are incredibly proud to have 68% of our colleagues that are women. The diversity of our colleagues allows us to gain new…

  Liked by Zhenyan Yan

• A major benefit of attending an in person conference, like #AUTM2022, was spending time with the many amazing people in this industry who are…

  

  A major benefit of attending an in person conference, like #AUTM2022, was spending time with the many amazing people in this industry who are…

  Liked by Zhenyan Yan

• TPCB students have the opportunity to work with outstanding faculty at the forefront of chemical biology. Our faculty have recently been recognized…

  

  TPCB students have the opportunity to work with outstanding faculty at the forefront of chemical biology. Our faculty have recently been recognized…

  Liked by Zhenyan Yan

• Congratulations to Alice Li, Executive Director at the Center for Technology Licensing at Cornell University (CTL) in Ithaca, on her election as a…

  

  Congratulations to Alice Li, Executive Director at the Center for Technology Licensing at Cornell University (CTL) in Ithaca, on her election as a…

  Liked by Zhenyan Yan

• Highlighting the postdocs who deserve credit for the work we are doing, Luisalberto Gonzalez, Balázs R. Varga and Soumen Chakraborty.

  

  Highlighting the postdocs who deserve credit for the work we are doing, Luisalberto Gonzalez, Balázs R. Varga and Soumen Chakraborty.

  Liked by Zhenyan Yan

• We are proud to announce our $75 million Series C financing, which will be used to expand our biotechnology ecosystem. Thank you to our lead…

  

  We are proud to announce our $75 million Series C financing, which will be used to expand our biotechnology ecosystem. Thank you to our lead…

  Liked by Zhenyan Yan

• Another one has been inked during the pandemics, nothing could stop us from moving forward ...

  

  Another one has been inked during the pandemics, nothing could stop us from moving forward ...

  Liked by Zhenyan Yan

• Very excited for another licensing agreement to further enhance our growing biotherapeutics portfolio!

  

  Very excited for another licensing agreement to further enhance our growing biotherapeutics portfolio!

  Liked by Zhenyan Yan